Eurofins Expands its Transplantation Testing Footprint with the Acquisition of Transplant Genomics Inc.
Eurofins Scientific (EUFI.PA), announces that it has successfully closed the acquisition of Transplant Genomics Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by genomics. TGI’s innovative non-invasive tests for the management of patients with silent inflammation and rejection following kidney transplants will strengthen and complement Eurofins’ industry leading global Transplant Diagnostics offerings.